Molecular Dosimetry Methods for Assessing Human Aflatoxin Exposures
- 1 January 1994
- book chapter
- Published by Elsevier
Abstract
No abstract availableThis publication has 37 references indexed in Scilit:
- Selective G to T mutations of p53 gene in hepatocellular carcinoma from southern AfricaNature, 1991
- Preparation of the 8,9-epoxide of the mycotoxin aflatoxin B1: the ultimate carcinogenic speciesJournal of the American Chemical Society, 1988
- Serum albumin adducts in the molecular epidemiology of aflatoxin carcinogenesis: correlation with aflatoxin B1 intake and urinary excretion of aflatoxin M1Carcinogenesis: Integrative Cancer Research, 1988
- Aflatoxins in human breast milkPaediatrics and International Child Health, 1984
- The inhibitory effects of ethoxyquin on the carcinogenic action of aflatoxin B1 in ratsCancer Letters, 1983
- Base substitution mutations induced by metabolically activated aflatoxin B1.Proceedings of the National Academy of Sciences, 1983
- Detection of putative adduct with fluorescence characteristics identical to 2,3-dihydro-2-(7′-guanyl)-3-hydroxyaflatoxin B1 in human urine collected in Murang'a district, KenyaCarcinogenesis: Integrative Cancer Research, 1983
- Identification of the principal aflatoxin B1-DNA adduct formed in vivo in rat liver.Proceedings of the National Academy of Sciences, 1978
- Structural identification of the major DNA adduct formed by aflatoxin B1 in vitro.Proceedings of the National Academy of Sciences, 1977
- Aflatoxin M1 in Human UrineNature, 1970